The mechanisms by which the anti-tumor activity of CDDP is achieved have been studied extensively in various cancer cells, and there is strong evidence that CDDP exerts anticancer effects mainly by interacting with DNA resulting in DNA damage and activating the enzyme NADPH oxidase to trigger an excessive production of ROS [23,24]. The gene discussed is FMO5; the disease is neoplasm.